stockrow
Friday 6 November 2026
Export PHR’s income statement to Excel — free account
Phreesia, Inc.
PHR Healthcare Health Information Services
Phreesia, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $480.6 million, up 14.5% from fiscal 2025.
- Revenue
- +10.4%
- EPS
- +200.0%
- Free cash flow
- +43.5%
- Total debt
- +3,191.9%
Quarter to July 2026, against a year earlier
12.56
0.15
−1.18%
Follow PHR
Alert me
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 5 | 7 |
+8 more TTM periods Free account |
| 3.12% | 2.86% | 0.77% | (1.87%) | ||
| 1.98% | 1.72% | 0.44% | (1.35%) | ||
ROIC |
1.74% | 0.46% | (0.94%) | (2.49%) | |
Return on Tangible Assets |
8.18% | 6.77% | 1.97% | (3.30%) | |
Average Days of Receivables |
96.52 | 105.54 | 117.44 | 69.55 | |
Free Cash Flow per Share |
1.09 | 1.04 | 0.91 | 0.58 | |
Free Cash Flow |
67.52 | 63.33 | 54.42 | 35.09 | |
Capital Expenditures |
(23.86) | (24.55) | (24.40) | (26.32) | |
| Other line items | |||||
Cash ROIC |
11.34% | 10.38% | 9.28% | 8.16% | |
Accounts Receivable Turnover |
4.81 | 4.54 | 4.21 | 5.80 | |
Accounts Payable Turnover |
17.58 | 21.12 | 18.03 | 13.34 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
27.08 | 27.23 | 27.18 | 15.41 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
2.78 | (9.85) | (1.26) | 0.35 | |
Research and Development Expense of Revenue |
22.90% | 23.81% | 25.28% | 25.95% | |
Selling, General and Administrative Expense of Revenue |
34.84% | 36.37% | 37.48% | 37.95% | |
Share Based Compensation of Revenue |
11.70% | 12.87% | 14.04% | 14.37% | |
Interest Coverage |
1.19 | 0.37 | (0.83) | — | |
Operating CF/Net income |
8.75 | 9.57 | 34.18 | (11.42) | |
Depreciation/Fixed assets |
2.26 | 1.87 | 1.72 | 1.39 | |
Capex/Depreciation |
(0.58) | (0.64) | (0.70) | (0.89) | |
Revenue per Share |
8.21 | 8.13 | 8.05 | 7.72 | |
Operating CF per Share |
1.48 | 1.44 | 1.32 | 1.02 | |
Capex per Share |
(0.39) | (0.40) | (0.41) | (0.44) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.06 |
Columns are period end dates · fundamentals updated 26 Oct 2026